Development of a New Risk Stratification Scheme to Predict Warfarin-Associated Hemorrhage: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study

被引：0
|
作者：
Fang, Margaret C.
Go, Alan S.
Chang, Yuchiao
Borowsky, Leila H.
Pomernacki, Niela K.
Udaltsova, Natalia
Singer, Daniel E.
机构：
[1] UCSF, San Francisco, CA USA
[2] Kaiser Permanente No Calif, Oakland, CA USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Anticoagulation; Atrial fibrillation; Risk factors;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16443
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A New Risk Scheme to Predict Warfarin-Associated Hemorrhage The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study
    Fang, Margaret C.
    Go, Alan S.
    Chang, Yuchiao
    Borowsky, Leila H.
    Pomernacki, Niela K.
    Udaltsova, Natalia
    Singer, Daniel E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (04) : 395 - 401
  • [2] Age and the risk of warfarin-associated hemorrhage: The anticoagulation and risk factors in atrial fibrillation study
    Fang, Margaret C.
    Go, Alan S.
    Hylek, Elaine M.
    Chang, Yuchiao
    Henault, Lori E.
    Jensvold, Nancy G.
    Singer, Daniel E.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (08) : 1231 - 1236
  • [3] Intracranial hemorrhage is the dominant determinant of death and disability from warfarin-associated hemorrhage: The anticoagulation and risk factors in atrial fibrillation (atria) study.
    Fang, MC
    Go, AS
    Chang, Y
    Hylek, EM
    Henault, L
    Jensvold, N
    Singer, D
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2005, 20 : 86 - 86
  • [4] The ATRIA Risk Scheme to Predict Warfarin-Associated Hemorrhage Not Ready for Clinical Use
    Olesen, Jonas B.
    Pisters, Ron
    Roldans, Vanessa
    Marin, Francisco
    Lane, Deirdre A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (02) : 194 - 195
  • [5] The ATRIA Risk Scheme to Predict Warfarin-Associated Hemorrhage Not Ready for Clinical Use Reply
    Fang, Margaret C.
    Go, Alan S.
    Singer, Daniel E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (02) : 195 - 195
  • [6] Anticoagulation intensity and risk of stroke and intracranial hemorrhage in atrial fibrillation: The Anticoaguation and Risk Factors in Atrial Fibrillation (ATRIA) study
    Hylek, EM
    Go, AS
    Chang, YC
    Phillips, KA
    Henault, LE
    Selby, JV
    Singer, DE
    CIRCULATION, 2001, 104 (17) : 794 - 794
  • [7] Predictors of warfarin use post stroke in atrial fibrillation: The AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study
    Hylek, EM
    Go, AS
    Chang, YC
    Phillips, KA
    Henault, LE
    Capra, AM
    Jensvold, NG
    Selby, JV
    Singer, DE
    CIRCULATION, 2002, 106 (19) : 727 - 728
  • [8] Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
    Go, AS
    Hylek, EM
    Borowsky, LH
    Phillips, KA
    Selby, JV
    Singer, DE
    ANNALS OF INTERNAL MEDICINE, 1999, 131 (12) : 927 - +
  • [9] Improving risk stratification in atrial fibrillation: Renal dysfunction and risk of thromboembolism and death in nonvalvular atrial fibrillation. The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study.
    Go, AS
    Hylek, EM
    Udaltsova, N
    Chang, YC
    Jensvold, NG
    Henault, LE
    Singer, DE
    CIRCULATION, 2004, 109 (07) : E92 - E92
  • [10] Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation - The anticoagulation and risk factors in atrial fibrillation (ATRIA) study
    Go, AS
    Hylek, EM
    Phillips, KA
    Borowsky, LH
    Henault, LE
    Chang, YC
    Selby, JV
    Singer, DE
    CIRCULATION, 2000, 102 (01) : 11 - 13
12345